Literature DB >> 2028752

Eye injuries in northern Sweden.

E Mönestam1, U Björnstig.   

Abstract

An analysis of 927 eye injuries treated at the University Hospital of Umeå, Northern Sweden, during a one-year period has been made. The estimated incidence was 8.1 per 1000 population. 86% of the injured were men. An overrepresentation of severe injuries were found in children and young adults, aged 10-19 years. 94.5% of the injuries were minor. The most common diagnosis was foreign body adherent to cornea or conjunctiva (40%). All chemical injuries were superficial. One-third of the sports injuries were caused by hockey-bockey and indoor bandy. Most of these were major injuries. The total cost of the injuries was assessed at SEK 1300,000. More information to the public concerning use of safety glasses and potential risks of eye trauma could reduce eye injury incidence.

Entities:  

Mesh:

Year:  1991        PMID: 2028752     DOI: 10.1111/j.1755-3768.1991.tb01982.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

1.  Epidemiology and sociodemographic aspects of ocular traumatic injuries in Iran.

Authors:  Alireza Keshtkar Jafari; Faramarz Anvari; Ahmad Ameri; Shima Bozorgui; Nooshin Shahverdi
Journal:  Int Ophthalmol       Date:  2010-10-06       Impact factor: 2.031

2.  [Severe open globe injury. New treatment concepts].

Authors:  W F Schrader; A Viestenz
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

3.  Ocular Trauma Score as prognostic value in traumatic ocular injuries due to rotating wire brushes.

Authors:  Konstantine Purtskhvanidze; Florian Rüfer; Alexa Klettner; Christoph Borzikowsky; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-16       Impact factor: 3.117

4.  Rotating wire brush ocular trauma in a fighter pilot.

Authors:  Karmiris I Efthymios; Manousakis E Evangelos; Ntravalias G Thomas; Kasmas M Konstantinos; Giannakis P Ioannis
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.